Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the ...
Despite the widespread popularity of new weight-loss medications, research suggests a non-drug alternative is significantly ...
Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback